The multifunctional delivery vector decorated by AS1411 conjugated hyaluronic acid and NLS‐GE11 peptide conjugated hyaluronic acid can specifically target circulating malignant cells (CMCs) of cancer patients to deliver the genome editing plasmid for epidermal growth factor receptor (EGFR) knockout. The gene discussed is EGFR; the disease is cancer.